期刊文献+

浸润性T淋巴细胞及Th细胞因子在不同类型乳腺癌中的表达 被引量:4

Expression of infiltrating T lymphocytes and T helper cytokines in different types of breast cancer
原文传递
导出
摘要 目的研究浸润性T淋巴细胞和Th细胞因子在不同类型乳腺癌中表达的意义。方法利用免疫组织化学链霉亲和素生物素法(labelled streptavidin-biotin method,LSAB)方法检测61例浸润性微乳头状癌(invasive micropapillary carcinoma,IMPC)、71例浸润性导管癌(invasive ductal carcinoma,IDC)和27例髓样癌(medullary carcinoma,MC)3种乳腺癌中浸润T淋巴细胞亚群分布以及Th细胞因子的表达。T淋巴细胞组间比较采用Kruskal-WallisTest,组内比较采用Wilcoxon Signed RanksTest;组间Th细胞因子的比较采用χ2检验。结果CD3、CD8和CD4均表达于淋巴细胞胞膜。CD3+T细胞在3组间差异无统计学意义(P=0.735)。CD8+T和CD4+T细胞在3组间差异均有统计学意义(P=0.000,P=0.012)。Th细胞因子主要表达于肿瘤细胞和淋巴细胞的胞质。IL-2表达在IMPC组最低(25/61,41.0%),其次是IDC组(33/71,46.5%),最高是MC组(20/27,74.1%),3组间差异有统计学意义(P=0.014);IFN-γ的表达类似于IL-2,IMPC组最低(39/61,63.9%),其次是IDC组(57/71,80.3%),最高是MC组(24/27,88.9%),3组间差异有统计学意义(P=0.019);IL-4的表达在IDC组最高(42/71,59.2%),其次是IMPC组(19/61,31.1%),最低是MC组(5/27,18.5%),3组间差异有统计学意义(P=0.000);IL-10的阳性率在IMPC组是87.8%(47/61),在IDC组是87.3%(62/71),在MC组是88.9%(24/27),3组间差异无统计学意义(P>0.050)。结论浸润性T淋巴细胞和Th细胞因子在不同类型乳腺癌中表达不同。 Objective To study the expression of tumor-infiltrating lymphocytes (TILs) and T helper cytokines in invasive micropapillary carcinoma (IMPC), invasive ductal carcinoma (IDC) and medullary carcinoma (MC) of the breast. Methods Three T-cell markers including pan-T cell marker (CD3), T-helper cell marker (CD4), cytotoxie T cell marker (CD8), and four T-helper cytokines including interleukin-2 (IL-2), interferongamma (IFN-γ), interleukin-4 (IL-4), and interleukin-10 (IL-10) were tested immunohistochemically in the three groups, (IMPC n=61, IDC n=71, and MC n=27) on formalin-fixed, paraffin embedded tumors. Kruskal-Wallis Test and Wilcoxon Signed Ranks Test were used for analysis of TILs;chi-square test was used for analysis of T helper cytokines. Results Markers, CD3, CD4 and CDS, all expressed in the cell membrane of lymphocytes. There was no statistical difference in CD3+T cells number between the three groups (P= 0. 705); CD8^+ T cells and CD4^+ T cells were statistically different between the three groups (P=0. 000,P=0. 012). T helper cytokines expressed in cytoplasm of tumour cells and lymphocytes. The expression of IL-2 was the highest in the MC group (20/27,74. 1%), followed by the IDC group (33/71,46. 5%), and the lowest in the IMPC group (25/61, 41.0%), there was a statistical difference between the three groups(P =0. 014). The expression of IFN-γ was the highest in the MC group (24/27,88. 9%) followed by the IDC group(57/71,80. 3%), and the lowest in the IMPC group(39/61,63.9%), there was a statistical difference between the three groups(P = 0. 019). The positive expression of IL-4 was the highest in the IDC group (42/71,59. 2%), followed by the IMPC group (19/61, 31.1%) and the lowest in the MC group (5/27, 18. 5%), there was a statistical difference between the three groups (P=0. 000). The positive rate of IL-10 expression was 87.8%(47/61)in the IMPC group, 87.3%(62/71) in the IDC group, and 88. 9%(24/27)in the MC group, with no statistical difference between the three groups. (P〉0. 050). Conclusion The expressions of infiltrating T lymphocytes and T helper cytokines were different in different types of breast carcinomas, which may be responsible for different biologic behavior.
出处 《中华乳腺病杂志(电子版)》 CAS 2009年第6期28-33,共6页 Chinese Journal of Breast Disease(Electronic Edition)
基金 国家自然科学基金资助项目(30600225) 教育部长江学者奖励计划乳腺癌创新团队(IRT0743) 国家"863"计划项目(2006AA02A249) 国家"973"计划项目(2009CB521700)
关键词 乳腺肿瘤 浸润T淋巴细胞 TH细胞因子 Breast neoplasms; Infiltrating T lymphocytes T helper cytokines
  • 相关文献

参考文献32

  • 1Tsuta K, Ishii G, Kim E, et al. Primary lung adenocarcinoma with massive lymphocyte infiltration. AmJ Clin Pathol, 2005, 123:547--552.
  • 2Canna K, McArdle P A, McMillan D C, etal. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer, 2005, 92:651--654.
  • 3Tavassoli F A, Devilee P. WHO classification of tumors: pathology, genetics, tumors of the breast and female genital organs. Lyon: IARC Press, 2003:35--36.
  • 4Tresserra F, Grases P J, Fabregas R, et al. Invasive micropapillary carcinoma: distinct features of a poorly recognized variant of breast carcinoma. Eur J Gynaecol Oncol, 1999, 20:205-- 208.
  • 5Middleton L P, Tressera F, Sohel M E, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol, 1999, 12: 499--504.
  • 6Luna More S, Casquero S, Perez-Mellado A, et al. Importance of eatrogen receptor for the behavior of invasive micropapillary carcinoma of the breast: review of 68 cases with follow-up of 54 months. Pathol Res Pract, 2000, 196: 35--39.
  • 7Luna More S, Gonzalez B, Acedo C, et al. Invasive micropapillary carcinoma of the hreast: a new special type of invasive mammary carcinoma. Pathol Res Praet, 1994, 190: 668--674.
  • 8Tsumagari K, Sakamoto G, Akiyama F, etal. The pathological diagnosis and clinical significance of invasive micropapillary carcinoma of the breast. Jpn J Breast Cancer, 2001, 16: 441-- 447.
  • 9Nassar H, Wallis T, Andea A, et al. Clinicopathologic analysis of invasive micropapillary differenciation in breast carcinoma. Mod Pathol, 2001, 14:836--841.
  • 10陈凌,范宇,郎荣刚,郭晓静,孙玉兰,付丽.伴有浸润性微乳头状癌结构乳腺癌的诊断和预后研究[J].中华病理学杂志,2007,36(4):228-232. 被引量:17

二级参考文献18

  • 1付丽.重视乳腺浸润性微乳头状癌的诊断[J].中华病理学杂志,2004,33(4):305-307. 被引量:26
  • 2范宇,郎荣刚,王颖,孙保存,付丽.乳腺浸润性微乳头状癌上皮性钙黏附素的表达及意义[J].中华病理学杂志,2004,33(4):308-311. 被引量:41
  • 3郭晓静,陈凌,郎荣刚,范宇,付丽.乳腺浸润性微乳头状癌的病理学特征与淋巴结转移的关系[J].中华病理学杂志,2006,35(1):8-12. 被引量:34
  • 4Sifiaunkgul S, Tavaasoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol, 1993, 6(6) :660-662.
  • 5Luna More S, Gonzalez B, Acedo C, et al. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol Res Pratt, 1994, 190 (7) :668-674.
  • 6Tavassoli FA, Devillee P. World Health Organization classification of tumors. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003:35-36.
  • 7Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. Ⅰ. The value of histological grade in breast cancer:experience from a large study with long-term follow-up.Histopathology, 1991, 19(5):403-410.
  • 8傅西林.乳腺癌组织学分级与放、化疗后的形态学改变//傅西林.乳腺肿瘤病理诊断图谱.北京:科学技术文献出版社,2003:136—140.
  • 9Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol, 1999, 12( 5 ) :499 -504.
  • 10Zekioglu O, .Erhan Y, Ciris M, et al. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology, 2004,44( 1 ) :18-23.

共引文献16

同被引文献39

  • 1沈月平,武俊青,张子豹,De-Kun Li,高尔生.雌激素相关基因及生殖因素对乳腺癌协同作用[J].中国公共卫生,2007,23(8):897-899. 被引量:7
  • 2Shimizu M, Saitoh Y, Itoh H. Imnmnohistochemical staining of Harasoneogene product in normal,benign and malignant human pancreatic tissues[J]. Hum PAthol, 1990, 21:607-612.
  • 3Danielson A,Tynning T. Interleukin 5 ,IL-6, IL-12, IFN-γ RANTES and Fractalkine in human nasal polyps,turbinate mucosa and serum[J]. Eur Arch Otorhinolaryngol,2006, 263 : 282-289.
  • 4Alcocer-Gonzalez JM, Berumen J,Tamez-Guerra R, et al. In vivo expression of immunosuppressive cytokines in hu- man papillomavirus-transformed cervical cancer cells [ J ]. Viral Immunol, 2006,19 ( 3 ) : 481-491.
  • 5Bais AG,Beekmann I,Lindemans J,et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN m lesions [J]. J Clin Pathol,2005,58 : 1096-1100.
  • 6Todaro M, Zerilli M, RicciVitiani L. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells [ J ]. Cancer Res,2006, 66 : 1491-1499.
  • 7Fan H,Walters CS,Dunston GM, et al. IL-12 plays a sig- nificant role in the apoptosis of human T cells in the absence of antigenic stimulation [ J ]. Cytokine, 2002, 19 : 126-137.
  • 8Gokce H, Durak MG, Akin MM, et al. Invasive micropapillary carcinoma of the breast:a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma [J]. Breast J,2013,29(5) :121 - 128.
  • 9Flatley E,Ang D, Warrick A, et al. PIK3CA, P-AKT pathway mutations in micropapillary breast carcinoma [ J ]. Hum Pathol, 2013,24(7) :S46 - S51.
  • 10Simonetti S, Terracciano L, Zlobec I, et al. Immunophenotyping analysis in invasive micropapillary carcinoma of the breast:role of CD24 and CD44 isoforms expression[J]. Breast, 2012,21 (2) :165 -170.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部